ReviewArchives of microbiology2026
From structure to design: experimental and AI-driven approaches in receptor-binding protein engineering for reprogramming phage host range.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Innovative Applications of Artificial Intelligence in Bacteriophage Research: A New Chapter in Future Medicine.Microorganisms · 2026Review
- Artificial Intelligence in Bacteriophage Science: A Comprehensive Narrative Review of Applications, Challenges, and Translational Opportunities.Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The emerging crisis of antimicrobial resistance has renewed interest in bacteriophage (phage) therapy as a promising alternative. The efficacy of phage therapy primarily depends on the specific interaction between the phage’s receptor-binding proteins (RBPs) and receptors on the bacterial surface. RBPs are critical for host recognition and infection, and engineering RBPs to alter host range and tropism is a key strategy for improving phage-based treatments. Recently, artificial intelligence (AI)-based tools have emerged as enabling technologies for protein engineering, ranging from predicting RBP structures using tools like AlphaFold to optimizing binding interactions through directed evolution, chimeric design, and deep learning-assisted host range prediction. In this review, we summarize the distinct structural features of RBPs and the main engineering strategies employed to modify them. We further evaluate the application of AI-driven approaches in RBP engineering, discussing current methodologies, including structure prediction, directed evolution, and deep learning-assisted host range prediction, along with current challenges such as data scarcity, model interpretability, bottlenecks in high-throughput experimental validation, and biosafety and ethical concerns. Finally, we outline future directions for leveraging the integration of experimental and AI-driven approaches to advance the rational design of next-generation phage therapeutics with tailored host specificity and improved efficacy against multidrug-resistant bacterial infections.
Indexed as
Identifiers
41843138What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.